Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer's disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Eurobio Scientific SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Eurobio Scientific SA Company Overview
- Eurobio Scientific SA Company Snapshot
- Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
- Eurobio Scientific SA - Pipeline Analysis Overview
- Eurobio Scientific SA - Key Facts
- Eurobio Scientific SA - Major Products and Services
- Eurobio Scientific SA Pipeline Products by Development Stage
- Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
- Eurobio Scientific SA Pipeline Products Overview
- CO-3S Companion Diagnostic Assay
- CO-3S Companion Diagnostic Assay Product Overview
- Companion Diagnostic Test - Breast Cancer
- Companion Diagnostic Test - Breast Cancer Product Overview
- DHT Dx15
- DHT Dx15 Product Overview
- DHT Dx15 Clinical Trial
- DIAG-3S Diagnostic Assay
- DIAG-3S Diagnostic Assay Product Overview
- Disease Evolution Predictive Test - AIDS
- Disease Evolution Predictive Test - AIDS Product Overview
- EBS 1005
- EBS 1005 Product Overview
- EBX-044
- EBX-044 Product Overview
- EHT Dx 11
- EHT Dx 11 Product Overview
- EHT Dx 12
- EHT Dx 12 Product Overview
- EHT Dx13
- EHT Dx13 Product Overview
- EHT Dx14
- EHT Dx14 Product Overview
- EHT Dx23
- EHT Dx23 Product Overview
- EurobioPlex SARS-CoV-2 SNPs Test
- EurobioPlex SARS-CoV-2 SNPs Test Product Overview
- T-COR 8 - Dengue Fever
- T-COR 8 - Dengue Fever Product Overview
- T-COR 8 - Meningitis
- T-COR 8 - Meningitis Product Overview
- Therapeutic Drug Monitoring Test - Resistant Cancer
- Therapeutic Drug Monitoring Test - Resistant Cancer Product Overview
- VAC-3S Companion Diagnostic Test
- VAC-3S Companion Diagnostic Test Product Overview
- Eurobio Scientific SA - Key Competitors
- Eurobio Scientific SA - Key Employees
- Eurobio Scientific SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ipsen SA
- ERYTECH Pharma SA
- Biosynex SA
- Laboratoire HRA Pharma SAS
- IntegraGen SA
- Innate Pharma SA